Extended Follow-Up Safety and Efficacy Results of Belantamab Mafodotin (Belamaf) 1.92 Mg/Kg Or 2.5 Mg/Kg Combined with Pom and Dex for the Treatment of Relapsed/Refractory Multiple Myeloma